Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

NCT05534438

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

NCT06110793

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

NCT02422641

Conditions
Breast Diseases, Breast Neoplasms, Central Nervous System Neoplasms, +9 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Siteman Cancer Center- Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Comprehensive Cancer Center at Wake Forest University (CCCWFU) Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

NCT05696626

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Providence Medical Foundation - Santa Rosa, CA Santa Rosa, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 224 locations
View Trial Details
Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

NCT05573126

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Breast Cancer, +6 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

Scalp Cooling in MBC

NCT04986579

Conditions
Breast Diseases, Breast Neoplasms, Chemotherapy-induced Alopecia, +5 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

NCT05029999

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +5 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions